Evidence map›Paper›PMID 33375102›Full record

ArticleMolecules (Basel, Switzerland)2020

Development of Second Generation Activity-Based Chemical Probes for Sirtuins.

Alyson M Curry, Elizabeth Barton, Wenjia Kang, Daniel V Mongeluzi, Yana Cen

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Biomolecules · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alyson M CurryDepartment of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.ORCID 0000-0003-2996-4519
Elizabeth BartonDepartment of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.
Wenjia KangDepartment of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.
Daniel V MongeluziDepartment of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.
Yana CenDepartment of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.
Virginia Commonwealth University · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
Novel Probes for Sirtuins: A Chemical Biology ApproachR15GM123393 · NIGMS · ALBANY COLLEGE OF PHARMACY · PI HASS, MARTHA A. · 2017 to 2017
$480k
NCATS NIH HHS UL1 TR002649NCATS NIH HHS UL1TR002649NIGMS NIH HHS P20 GM103449NIGMS NIH HHS R15 GM123393NIH HHS 1R15GM123393NIH HHS P20GM103449
6 · The paper itself

Abstract

NAD

Indexed as

Chemistry Techniques, SyntheticDiazomethaneDrug DesignDrug DiscoveryHistone Deacetylase InhibitorsHumansIsoenzymesLigandsMolecular ProbesMolecular StructureNADSirtuinsStaining and LabelingStructure-Activity RelationshipDiazomethaneHistone Deacetylase InhibitorsIsoenzymesLigandsMolecular ProbesNADSirtuinsactivity-basedchemical probessirtuin

Identifiers

PMID33375102
PMCPMC7792806
OpenAlexW3115380120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.